Filter Results:
(619)
Show Results For
- All HBS Web
(619)
- People (4)
- News (103)
- Research (424)
- Events (3)
- Multimedia (4)
- Faculty Publications (261)
Show Results For
- All HBS Web
(619)
- People (4)
- News (103)
- Research (424)
- Events (3)
- Multimedia (4)
- Faculty Publications (261)
- 01 Sep 2014
- News
Afghanistan’s Hope and Light
considerably. He went on to earn advanced degrees in biochemistry and management science and immigrated with his new wife, Shainoor, to Vancouver. After a brief stint at a pharmaceutical company (“I’m an... View Details
Keywords: Julia Hanna
- 26 Jul 2010
- Research & Ideas
Yes, You Can Raise Prices in a Downturn
As economic turmoil continues, many companies are reconsidering their strategies with an eye toward going lean and slashing prices. And that might work for a few companies—but very few. Instead, companies... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
Protection Agency (US EPA) program that encourages companies to self-disclose violations of environmental laws and regulations in exchange for reduced sanctions. We find that facilities are more likely to self-disclose if they were... View Details
Keywords: Sean Silverthorne
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
The U.S. Food and Drug Administration, which was created by the passage of the 1906 Federal Food and Drugs Act, regulates companies and industries accounting for one-quarter of all consumer spending, roughly $1.5 trillion worth of... View Details
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into 16... View Details
Keywords: Carmen Nobel
- Web
Winners & Success Stories | New Venture Competition
considerable achievement gains while building their self-confidence. The Company collaborates with parents, schools, community organizations, and local educators to implement programs that will help students succeed in school, and... View Details
- 20 Feb 2018
- First Look
First Look at New Research and Ideas, February 20, 2018
new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by... View Details
Keywords: Carmen Nobel
- 01 Mar 2014
- News
My HBS Eureka Moment
uncomfortable with the ethnic background of the proponents, who were proposing to start a pharmaceutical company in Mexico. I could never get comfortable, and missed a huge opportunity. The product was the... View Details
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
The first question focuses on motivations, while the second one has more to do with the benefits sought in interactions with future partners. Altruism As a general rule, collaboration efforts between companies and CSOs have an inherent... View Details
- 13 Jan 2009
- First Look
First Look: January 13, 2009
Case 708-479 This case on the globalization of East Asian pop music is useful for teaching concepts of regional business strategy and also of cultural arbitrage. Music companies in the case must examine why certain markets are clearly... View Details
Keywords: Martha Lagace
- 26 Apr 2011
- Op-Ed
HBS Faculty Comment on Environmental Issues for Earth Day
have been experimenting with integrated project delivery—a collaborative process that involves unprecedented teamwork and shared decision making throughout a design and building project. A number of companies are developing... View Details
- 03 Feb 2015
- First Look
First Look: February 3
architecture, including business- and technology-related aspects. We apply our methodology to data gathered in a large pharmaceutical firm. We show that this methodology helps to identify layers in the firm's architecture associated with... View Details
Keywords: Sean Silverthorne
- 02 Apr 2013
- First Look
First Look: April 2
care needs to go "beyond the pill" and systematically integrate combinations of treatments. We discuss the implications of this approach for organizational and business models in the pharmaceutical industry. 2006 World Politics... View Details
Keywords: Sean Silverthorne
- 27 May 2009
- First Look
First Look: May 27, 2009
Case 509-048 The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical... View Details
Keywords: Martha Lagace
- 24 May 2011
- First Look
First Look: May 24
4,646 public companies in many industries, headquartered in 46 countries during 2005-2008, when environmental disclosure increased among many global corporations. Controlling for a host of organizational, industry, and national... View Details
Keywords: Sean Silverthorne
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details
Keywords: Martha Lagace
- 05 May 2023
- News
Fail Better
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Every year, HBS selects a small handful of outstanding alums to receive its most important honor, the Alumni Achievement Award. This year's recipients work in finance, politics, biopharma, and... View Details
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
- 05 Aug 2008
- First Look
First Look: August 5, 2008
/b01/en/common/item_detail.jhtml?id=808167 The Coartem Challenge (A) Harvard Business School Case 706-037 In November 2005, Novartis, a major global pharmaceutical firm, is reviewing its Coartem program, an ambitious attempt to deliver... View Details
Keywords: Martha Lagace